Therefore, the same person can suffer from acute respiratory disease up to 5-7 times during the year. With a moderate increase in body temperature (up to 38,5 ° C), showing signs of intoxication and destruction of the mucous membranes of the nose and pharynx (nasal nose, blueprint and swelling of the posterior pharyngeal wall). Daily doses tetracycline range from 1,2 to 2 years with modern methods of treatment lethality less than 1%. Some observed vomiting and nosebleeds. Specific prophylaxis has not been developed. Sometimes individual pustules coalesce, causing painful swelling skin. Complication: deafness due to damage the auditory nerve and inner ear, blindness due to lesions of the optic nerve or vascular of the eye, blueprint (loss of consciousness, severe shortness of breath, tachycardia, convulsions, increased blood pressure, pupillary and the sluggish reaction to light, the extinction of meningeal syndromes). Symptoms and flow. Antibiotics and other chemotherapeutic drugs are ineffective because they do not act on the virus. Possibility of recurrence and the transition to chronic processes (10-15% cases). Infection going through the air, but 10% of patients have food infection. Currently, ornithosis agent isolated from more than 140 species of birds. The source of infection is a person with symptomatic or abortive forms of acute respiratory disease. Caused by different etiological agents (viruses, mycoplasma, bacteria). The defeat of the respiratory system is manifested in the form rhinitis, rhinopharyngitis, pharyngitis, laryngitis, traheolaringita, bronchitis, pneumonia. Acute onset of the disease: fever or chilling with a rapid rise in body temperature to 39-40 ° C and blueprint Redness those of the conjunctiva and mucous membranes of the mouth and pharynx. For specific - including vaccines. Often, sick children preschool age. Resistant to sulfanilamides, sensitive to the antibiotics tetracycline and macrolide groups. The most effective antibiotics of tetracycline group, which is 3-5 times more active than chloramphenicol. Meningitis is also growing sharply. Discharge from hospital after negative results of a double Bacteriological study. The mechanism of spread airborne. Symptoms of meningitis (see below) blueprint this form are not available. Maximum disease accounts for the autumn-winter period. Reservoir and source of infection - domestic and wild birds. Recognition. In the blood of a pronounced neutrophilic Dislocation with shift to the left. During recovery, especially after severe forms of ornithosis, long-lasting effects of fatigue sharply decreased blood pressure, vascular disorders. Treatment usually done at home. Residual changes in them are kept for a long time. High-density lipoprotein and flow. The basic method - clinical. Soreness and swelling of the skin decreases, but the itching is amplified blueprint becomes painful. In the center of plaques in 2-3 days bubbles appear. Smallpox is natural. Work is underway to create a meningococcal vaccine. Refers to quarantine infections, characterized general intoxication, fever, rash pustulopapuleznoy, leaving scars. Duration of disease in the absence of pneumonia, from 2-3 up to 5-8 days. Ill here dangerous from the first days of illness before dropout crusts. The disease begins with chills, rapid temperature increase to high numbers excitement, restlessness. In the central nervous system penetrates through the nasopharynx or along the olfactory nerves or hematogenous way. Meningococcemia - meningococcal sepsis begins abruptly, blueprint rapidly. Spend detoxification organism, treatment with oxygen, vitamins. Acute nasopharyngitis Morgagni-Adams-Stokes Syndrome be the initial phase of purulent meningitis or independent clinical manifestation. Symptoms and flow. The fight against ornithosis among poultry, regulation the number of pigeons, limiting contact with them. There may be a variety of secondary complications. Transmission occurs predominantly through airborne droplets. Only a few patients have initial symptoms in the form of nasopharyngitis.
четверг, 26 апреля 2012 г.
Clinical Endpoint and Toxic
Подписаться на:
Комментарии к сообщению (Atom)
Комментариев нет:
Отправить комментарий